Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2017.1273344
Abstract: ABSTRACT Introduction: Generating effective RNAi-based therapies with the potential to achieve leukemia remission remains critical unmet need. Despite a growing number of leukemia clinical trials, tissue specific delivery of therapeutic siRNA is a major roadblock… read more here.
Keywords: therapy antibody; sirna conjugates; antibody sirna; leukemic therapy ... See more keywords